Rihab Mansour1, Narges Salehi2, William Tanguay1,3, Guillaume Gilbert4, Catherine Huet1, Gilles Soulez1, Pierre Perreault1, Damien Olivé 1, An Tang1,3, and Samuel Kadoury1,2
1Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada, 2École Polytechnique, Montréal, QC, Canada, 3Department of Radiology, Radio-Oncology and Nuclear Medicine, Université de Montréal, Montréal, QC, Canada, 4MR Clinical Science, Philips Healthcare Canada, Markham, ON, Canada
1Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada, 2École Polytechnique, Montréal, QC, Canada, 3Department of Radiology, Radio-Oncology and Nuclear Medicine, Université de Montréal, Montréal, QC, Canada, 4MR Clinical Science, Philips Healthcare Canada, Markham, ON, Canada
4D flow MRI measurements in the abdominal aorta, common
hepatic artery, and proper hepatic arteries are feasible and provide repeatable
values before and after transarterial chemoembolization in patients with
hepatocellular carcinoma.
Figure 1. 3D
segmentation at the level of the abdominal aorta (upper left) and corresponding
4D flow particle tracing from a 68-year-old man (lower left). Representative
flow curves in the abdominal aorta, common hepatic artery and proper hepatic
artery (right).
Table 2. Statistical analysis between pre- and post-TACE for
abdominal aorta, common hepatic artery, and proper hepatic artery.